title: Novel anticoagulant use for venous thromboembolism: a 2013 update.
abstract: Many pharmacologic options are available for prevention and treatment of venous thromboembolism (VTE). The anticoagulant selected may vary according the individual patient situation such as the acute versus chronic setting, renal function and indication for either VTE prevention or treatment. Established methods of pharmacologic prophylaxis agents include heparinoids, injectable anti-Xa inhibition and vitamin K antagonists (VKA). The novel anticoagulants have recently been incorporated into orthopedic surgery prophylaxis pathways and can be used for VTE treatment. Chronic VTE management, however, has largely been managed with the use VKA. The advantages of VKA include low cost, familiarity with use, and established protocols to manage catastrophic bleeding. VKA use, however, poses hurdles including the fact that correct dosing can be empiric, the existence of multiple potential medication and dietary interactions, and the possiblity for complications when anticoagulation levels are not well monitored. In contrast, the novel anticoagulants offer ease of dosing, reliable pharmacokinetics and low risk of interactions with other medications or diet. Potential hazards of the novel anticoagulants include high costs, questionable therapeutic benefit in those with poor adherence, a reliance on renal clearance, lack of reliable reversibility in the event of catastrophic bleeding, as well as incomplete familiarity with use by the general practitioner. Although clinical trials demonstrate promise of greater applicability of use of these novel agents, hospital systems will need to simultaneously create a plan for appropriate management of the use of these agents, an anticoagulation stewardship program. As guidelines are adopted to prevent and manage VTE, an appreciation for this new level of complexity is essential.
authors: Jefferson Vascular Center, Jefferson Medical College, Thomas Jefferson University Hospitals, 111 S. 11th Street, Suite 6270, Philadelphia, PA, 19107, USA, alejandro.perez@jefferson.edu.
authors: Alejandro
authors: A
authors: Perez
authors: Geno J
authors: GJ
authors: Merli
references: N Engl J Med. 2009 Dec 10;361(24):2342-52
references: 19966341
references: J Thromb Haemost. 2008 Aug;6(8):1313-8
references: 18541000
references: N Engl J Med. 2008 Jun 26;358(26):2776-86
references: 18579812
references: Semin Thromb Hemost. 2012 Nov;38(8):905-7
references: 23086541
references: MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4
references: 22672974
references: Thromb Res. 2010 Sep;126(3):175-82
references: 20434759
references: Ann Surg. 1938 Aug;108(2):163-77
references: 17857224
references: N Engl J Med. 2010 Dec 23;363(26):2487-98
references: 21175312
references: Am J Manag Care. 2011 Feb;17(1 Suppl):S27-32
references: 21517653
references: Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6
references: 21517652
references: Circulation. 1959 Jan;19(1):75-8
references: 13619023
references: N Engl J Med. 2012 Apr 5;366(14):1287-97
references: 22449293
references: Thromb Haemost. 2011 Apr;105(4):721-9
references: 21225098
references: Clin Appl Thromb Hemost. 2001 Oct;7(4):269-75
references: 11697707
references: Lancet. 2009 May 16;373(9676):1673-80
references: 19411100
references: Can Med Assoc J. 1938 Jan;38(1):59-61
references: 20320837
references: N Engl J Med. 2008 Jun 26;358(26):2765-75
references: 18579811
references: N Engl J Med. 2010 Dec 23;363(26):2499-510
references: 21128814
references: Chest. 2012 Feb;141(2 Suppl):e278S-e325S
references: 22315265
references: Lancet. 2008 Jul 5;372(9632):31-9
references: 18582928
references: Chest. 2012 Feb;141(2 Suppl):e195S-e226S
references: 22315261
references: Circulation. 2011 Oct 4;124(14):1573-9
references: 21900088
references: Lancet. 2007 Sep 15;370(9591):949-56
references: 17869635
references: J Thromb Haemost. 2007 Nov;5(11):2178-85
references: 17764540
references: Lancet. 2010 Mar 6;375(9717):807-15
references: 20206776
references: N Engl J Med. 2009 Aug 6;361(6):594-604
references: 19657123
references: J Thromb Thrombolysis. 2011 May;31(4):407-16
references: 21359646
references: J Arthroplasty. 2009 Jan;24(1):1-9
references: 18534438
references: N Engl J Med. 2011 Dec 8;365(23):2167-77
references: 22077144
references: Arch Intern Med. 2012 Mar 12;172(5):397-402
references: 22231617
references: Expert Rev Cardiovasc Ther. 2011 Jul;9(7):841-4
references: 21809964